Supernus Pharmaceuticals, Inc.

MD · United States · Reporting entity ID 100000011150

Total reported 2019–2025

$55.7M

#158 of 2,960 reporting companies — 0.1% of all reported industry payments

$19.5M in general payments across 354,972 records, plus $36.2M in research funding across 5,447 records.

How it breaks down

General payments $19,542,301

Research funding $36,204,624

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.